Not Rated
|
Fund Size
(0.07% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 06-Nov-25 | 10221.90 | 2.22% | - | 1.08% | 24/230 |
| 1 Month | 13-Oct-25 | 9890.60 | -1.09% | - | 1.62% | 222/227 |
| 3 Month | 13-Aug-25 | 10347.40 | 3.47% | - | 4.59% | 153/224 |
| 6 Month | 13-May-25 | 10416.60 | 4.17% | - | 8.85% | 197/214 |
| YTD | 01-Jan-25 | 9818.20 | -1.82% | - | 5.47% | 156/201 |
| 1 Year | 13-Nov-24 | 10005.80 | 0.06% | 0.06% | 8.94% | 169/187 |
| 2 Year | 13-Nov-23 | 14825.20 | 48.25% | 21.73% | 20.51% | 54/141 |
| Since Inception | 17-Jun-23 | 16075.40 | 60.75% | 21.76% | 14.30% | 31/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 13-Nov-24 | 12000 | 12470.4 | 3.92 % | 7.31 % |
| 2 Year | 13-Nov-23 | 24000 | 26238.08 | 9.33 % | 8.81 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Cipla Ltd. : Futures Near | Pharmaceuticals | 324.5 | 8.45% | 8.45% | 8.45% (Oct 2025) | 0% (Nov 2024) | 2.15 L | 0.02 Cr |
| Sequent Scientific Ltd. | Pharmaceuticals | 317 | 8.26% | 0.99% | 8.26% (Oct 2025) | 4.76% (Mar 2025) | 14.77 L | 0.00 |
| Zydus Wellness Ltd. | Packaged foods | 305.9 | 7.97% | 0.22% | 7.97% (Oct 2025) | 5.72% (Apr 2025) | 6.42 L | 0.00 |
| Aster DM Healthcare Ltd. | Hospital | 302.9 | 7.89% | -2.48% | 10.37% (Sep 2025) | 7.89% (Oct 2025) | 4.47 L | -1.80 L |
| Lupin Ltd. : Futures Near | Pharmaceuticals | 259.7 | 6.76% | 0.09% | 6.76% (Oct 2025) | 0% (Nov 2024) | 1.31 L | 0.80 L |
| SMS Pharmaceuticals Ltd. | Pharmaceuticals | 250.6 | 6.53% | 1.12% | 6.53% (Oct 2025) | 3.32% (Jan 2025) | 8.77 L | 43.93 k |
| Pfizer Ltd. | Pharmaceuticals | 249.8 | 6.51% | 0.13% | 7.14% (Dec 2024) | 5.22% (Mar 2025) | 47.95 k | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 247.5 | 6.45% | 0.23% | 6.84% (Dec 2024) | 5.8% (Jun 2025) | 2.17 L | 0.00 |
| Anthem Biosciences Ltd. | Biotechnology | 236.9 | 6.17% | -0.53% | 6.82% (Aug 2025) | 0% (Nov 2024) | 3.34 L | 0.00 |
| # Adani Enterprises Ltd. | Trading - minerals | 235.7 | 6.14% | 6.14% | 6.14% (Oct 2025) | 0% (Nov 2024) | 95.00 k | 95.00 k |
Investment / Portfolio Grades
| Security Type |
% Weight |
Category Average |
|---|---|---|
| Government Backed | 6.20% | 0.44% |
| Low Risk | 0.00% | 0.00% |
| Moderate Risk | 0.00% | 0.00% |
| High Risk | 0.00% | 0.00% |
| Very High Risk | 0.00% | 0.00% |
| Others | 0.00% | 0.00% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 15.82% |
| Net Receivables | Net Receivables | -19.48% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 4.21 | 14.03 | 46.24 | 44.70 | 37.87 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | -0.58 | 2.66 | 16.83 | 29.79 | 15.87 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 5.18 | 10.51 | 19.92 | 26.94 | 14.82 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.78 | 9.14 | 20.47 | 26.41 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 0.21 | 10.07 | 21.28 | 24.40 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 3.74 | 4.50 | 14.80 | 24.22 | 18.39 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 5.07 | 8.69 | 9.87 | 23.19 | 15.72 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 1.80 | 5.87 | 11.55 | 23.19 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 4.25 | 6.87 | 12.25 | 22.89 | 21.04 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 3.04 | 7.71 | 8.90 | 22.66 | 0.00 |
Out of 29 mutual fund schemes offered by this AMC, 1 is/are ranked 3 * , 5 is/are ranked 2 * , 5 is/are ranked 1 * , and 18 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Quant Small Cap Fund - Direct Plan - Growth | 3 | 30504.39 | 1.97 | 4.92 | 6.76 | 1.15 | 24.74 |
| Quant ELSS Tax Saver Fund - Direct Plan - Growth | 1 | 12444.11 | 3.34 | 7.50 | 9.24 | 6.54 | 16.18 |
| Quant Multi Cap Fund - Direct Plan - Growth | 1 | 9322.61 | 1.83 | 4.65 | 3.35 | 0.14 | 12.47 |
| Quant Mid Cap Fund - Direct Plan - Growth | 1 | 8525.04 | 1.47 | 2.01 | -1.11 | -0.11 | 18.03 |
| Quant Flexi Cap Fund - Direct Plan - Growth | 2 | 6889.95 | 3.34 | 7.49 | 5.10 | 5.28 | 17.70 |
| Quant Multi Asset Allocation Fund - Direct Plan - Growth | NA | 4056.73 | 1.30 | 8.53 | 12.91 | 16.74 | 22.14 |
| Quant Large and Mid Cap Fund - Direct Plan - Growth | 1 | 3548.74 | 3.23 | 4.73 | 3.03 | 3.00 | 18.04 |
| Quant Infrastructure Fund - Direct Plan - Growth | NA | 3302.59 | 1.61 | 5.46 | 6.10 | 2.85 | 18.54 |
| Quant Large Cap Fund - Direct Plan - Growth | 2 | 2823.91 | 3.03 | 5.33 | 8.65 | 6.21 | 16.64 |
| Quant Aggressive Hybrid Fund - Direct Plan - Growth | 2 | 2128.84 | 2.27 | 5.72 | 7.93 | 9.77 | 13.18 |